Clinical trial Recruiting at 1 site Observational Ages 20 to 79

Brillouin hydration mapping to study cornea health

Official title: A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases

Run by Massachusetts General Hospital · NCT07780890 · Data updated 2026-11-12

Researchers test a Brillouin microscope to see if it can measure corneal water content in healthy people and those with eye conditions.

Quick facts

Study typeObservational
Ages20 Years to 79 Years
SexAll
Enrollment90 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedAugust 18, 2026
Main results expectedSeptember 1, 2027
Study endsSeptember 1, 2027
Registry record updatedAugust 25, 2026
Trial IDNCT07780890 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with healthy eyes or those affected by the listed corneal/eye conditions, within the specified refractive range and without prior ocular surgery or active systemic disease.

Probably not a fit

Patients with recent ocular surgery, active ocular disease, or significant systemic illnesses may not benefit from this observational approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study seeks to develop and validate Brillouin-based hydration mapping as a noninvasive way to quantify water content in the cornea. The goal is to create a clinically viable method that could aid in early detection and better management of corneal diseases and postoperative issues. The approach relies on spatially resolved Brillouin frequency shifts to reflect hydration independently of corneal thickness. Participants include healthy volunteers and patients with conditions such as Fuchs endothelial corneal dysfunction, open-angle glaucoma, dry eye disease, keratoconus, and prior LASIK surgery. The study is conducted at Massachusetts General Hospital and collaborating centers, with inclusion criteria focused on adults with normal vision or within specific refractive ranges and without recent ocular surgeries or active systemic diseases.

Why it matters

Potential benefit: If successful, the method could provide clinicians with a new, hydration-based biomarker for corneal health that may improve diagnosis and management of corneal diseases and post-surgical outcomes.

How similar studies have gone: Prior work suggests Brillouin microscopy is sensitive to hydration and may map tissue properties, but clinical hydration mapping in vivo is still being validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy volunteers with normal eyes
* Visual acuity between +2 to -6 diopters

Exclusion Criteria:

* History of refractive or cataract surgery
* History of ocular disease
* Active non-ophthalmic systemic disease

Where it's running

  • Massachusetts General Brigham
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Seok-Hyun Yun, PhD — Massachusetts General Brigham
  • Study coordinator: Soyeon (Selina) Ahn, PhD
  • Email: sahn14@mgh.harvard.edu
  • Phone: 3396009736

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.